ETR vs REGN · P/E 28, rev $12.95B vs P/E 14, rev $14.34B
Entergy Corporation (ETR) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Entergy Corporation (ETR) is a utilities - regulated electric company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported ETR revenue for 2025-12-31 was $12.95B. Net income was $1.77B. Revenue was up 9.0% from 2024-12-31 to 2025-12-31. ETR currently screens at market cap $50.71B and trailing P/E 28.3.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
ETR currently screens at market cap $50.71B and trailing P/E 28.3. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the ETR and REGN stock pages for the full models.
Not investment advice.